STOCK TITAN

Arbe Robotics prices offering for estimated $15M

Net proceeds are intended for working capital and corporate purposes, including commercial scaling, defense and counter-drone expansion, and potential acquisitions.

(Neutral)
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

Arbe Robotics Ltd. (ARBE) priced an underwritten registered direct offering of 833,334 ordinary shares at $0.60 per share and pre-funded warrants to purchase up to 24,166,666 ordinary shares at $0.5999 per warrant. The warrants have a $0.0001-per-share exercise price and are immediately exercisable, including through cashless exercise.

Gross proceeds are estimated at approximately $15.0 million before underwriting discounts, commissions and offering expenses. Arbe intends to use net proceeds for working capital and general corporate purposes, including scaling operations for commercial opportunities, expanding into defense and counter-drone markets, and potentially pursuing strategic merger and acquisition opportunities. The company agreed to pay underwriting commissions and discounts equal to 6.0% of gross proceeds and reimburse $125,000 of expenses.

The offering is expected to close on or about September 28, 2026, subject to customary closing conditions. Warrant exercises are subject to beneficial-ownership and voting-power limits of 4.99% or 9.99%; a holder may change the applicable percentage on 61 days’ notice, to a level not exceeding 9.99%.

Filing Explained

The 6-K adds a post-closing issuance restriction to the offering: if it closes, Arbe has agreed, subject to exceptions, not to issue or agree to issue ordinary shares or securities convertible into or exercisable for them for 90 days, temporarily limiting additional issuance under that agreement.

Ordinary shares offered 833,334 shares Priced at $0.60 per share
Ordinary shares underlying pre-funded warrants Up to 24,166,666 shares Warrants offered at $0.5999 each
Share offering price $0.60 per share Ordinary shares
Pre-funded warrant offering price $0.5999 per warrant Each warrant covers one ordinary share
Pre-funded warrant exercise price $0.0001 per ordinary share Exercise price under the warrant terms
Estimated gross proceeds Approximately $15.0 million Before underwriting discounts, commissions and offering expenses
Underwriting commissions and discounts 6.0% of gross proceeds Payable by the company
Underwriter expense reimbursement $125,000 Payable by the company
underwritten registered direct offering financial
"priced an underwritten registered direct offering"
An underwritten registered direct offering is a way a company raises money by selling newly registered shares or bonds directly to selected investors, with an investment bank agreeing to buy and resell the securities so the company knows it will receive the cash. Think of the bank as a wholesaler that guarantees to take the inventory and find buyers; it speeds the sale but often means the securities are sold at a discount, which can dilute existing shareholders and affect the stock price.
pre-funded warrants financial
"pre-funded warrants to purchase up to 24,166,666 Ordinary Shares"
Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.
cashless exercise financial
"may be exercised by means of a cashless exercise"
A cashless exercise is a way for an option holder to convert stock options into actual shares without paying the purchase price in cash; instead they immediately give up a portion of the newly issued shares to cover the cost and any withholding taxes. Investors care because this process increases the number of shares available and can slightly dilute existing holdings, while also signaling how insiders or employees are realizing compensation without needing cash — similar to paying for a purchase by handing over part of what you just bought.
beneficially owned regulatory
"Ordinary Shares beneficially owned by such holder"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
underwriting commissions and discounts financial
"underwriting commissions and discounts equal to 6.0%"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much is ARBE’s offering expected to generate?

Arbe estimates approximately $15.0 million in gross proceeds before underwriting discounts, commissions and offering expenses. It intends to use net proceeds for working capital and general corporate purposes, including scaling operations, defense and counter-drone markets, and potential strategic merger and acquisition opportunities.

How many shares and pre-funded warrants are included in ARBE’s offering?

The offering includes 833,334 ordinary shares at $0.60 per share and pre-funded warrants to purchase up to 24,166,666 ordinary shares at $0.5999 per warrant. The warrants have an exercise price of $0.0001 per ordinary share.

When is ARBE’s offering expected to close?

The offering is expected to close on or about September 28, 2026, subject to the satisfaction of customary closing conditions.

What ownership limits apply to ARBE’s pre-funded warrants?

Exercise is limited if it would cause a holder and its affiliates to exceed 4.99% or 9.99% of the company’s outstanding ordinary shares or combined voting power. A holder may change the applicable percentage on 61 days’ notice to a higher or lower percentage not exceeding 9.99%.

How long is ARBE restricted from issuing additional shares under the underwriting agreement?

For 90 days following the closing, Arbe agreed not to issue, agree to issue, or announce the issuance or proposed issuance of ordinary shares or securities convertible into, exercisable for, or exchangeable for ordinary shares, subject to certain exceptions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16

OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of September 2026

 

Commission File Number: 001-40884

 

ARBE ROBOTICS LTD.

(Translation of registrant’s name into English)

 

HaHashmonaim St. 107

Tel Aviv-Yafo, Israel

Tel: +972-73-7969804, ext. 200

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

 

Form 20-F ☒       Form 40-F ☐

 

 

 

 

 

 

INFORMATION CONTAINED IN THIS CURRENT REPORT ON FORM 6-K

 

Underwriting Agreement

 

On September 25, 2026, Arbe Robotics Ltd. (“Arbe” or the “Company”), commenced an underwritten registered direct offering (the “Offering”) of an aggregate of 833,334 ordinary shares (the “Shares”), par value NIS 0.000216 per share, of the Company (the “Ordinary Shares”) and, in lieu of Ordinary Shares to certain investors, pre-funded warrants to purchase up to 24,166,666 Ordinary Shares (the “Pre-Funded Warrants,” and together with the Shares, the “Securities”). The Pre-Funded Warrants have an exercise price of $0.0001 per Ordinary Share and are immediately exercisable until exercised in full. The offering price for each Share was $0.60 and the offering price for each Pre-Funded Warrant was $0.5999, which equals the offering price per Ordinary Share sold in the Offering less the $0.0001 per share exercise price for each Pre-Funded Warrant. The Company does not intend to list the Pre-Funded Warrants on The Nasdaq Global Select Market (“Nasdaq”) or any other nationally recognized securities exchange or trading system.

 

The exercise price and the number of Ordinary Shares issuable upon exercise of the Pre-Funded Warrants are subject to appropriate adjustments in the event of certain stock dividends and distributions, stock splits, stock combinations, reclassifications or similar events affecting the Ordinary Shares. The Pre-Funded Warrants are exercisable from the date of issuance and may be exercised by means of a cashless exercise. Under the Pre-Funded Warrants, the Company may not effect the exercise of the Pre-Funded Warrants, and a holder will not be entitled to exercise any portion of the Pre-Funded Warrants that, upon giving effect to such exercise, would result in: (i) the aggregate number of Ordinary Shares beneficially owned by such holder (together with its affiliates) exceeding 4.99% (or 9.99%) of the number of Ordinary Shares outstanding immediately after giving effect to the exercise; or (ii) the combined voting power of the Company’s securities beneficially owned by such holder (together with its affiliates) exceeding 4.99% (or 9.99%) of the combined voting power of all of the Company’s securities outstanding immediately after giving effect to the exercise, as such percentage ownership is determined in accordance with the terms of the Pre-Funded Warrants, which percentage may be changed at the holder’s election to a higher or lower percentage not in excess of 9.99% upon 61 days’ notice to the Company.

 

Canaccord Genuity acted as the sole bookrunner for the Offering.

 

The gross proceeds from the Offering, before deducting underwriting discounts and commissions and offering expenses payable by the Company, described in more detail below, were approximately $15.0 million. The Company intends to use the net proceeds from the Offering for working capital and general corporate purposes, including, but not limited to, scaling its operations to support growing commercial opportunities, including the recently announced selection of Arbe’s radar technology for an L3 passenger vehicle program of one of the world’s largest automotive groups and its intended expansion into the defense and counter-drone markets, as well as to potentially pursue potential strategic merger and acquisition opportunities. The Offering is anticipated to close on or about September 28, 2026 (the “Closing”).

 

In connection with the Offering, the Company entered into an underwriting agreement (the “Underwriting Agreement”) with Canaccord Genuity LLC as the sole underwriter (the “Underwriter”). Pursuant to the Underwriting Agreement, the Company has agreed not to issue, enter into any agreement to issue or announce the issuance or proposed issuance of any Ordinary Shares or any securities convertible into, or exercisable or exchangeable for, Ordinary Shares, including the filing of a registration statement with the Securities and Exchange Commission (“SEC”) in respect thereof, subject to certain exceptions in each instance, for a period of ninety (90) days following the Closing.

 

The Underwriting Agreement contains customary representations, warranties, covenants and agreements by the Company, indemnification obligations of the Company, including for liabilities arising under the Securities Act of 1933, as amended (the “Securities Act”), other obligations of the parties and termination provisions. The representations, warranties and covenants contained in the Underwriting Agreement and the Pre-Funded Warrants were made only for the purposes of such agreement and as of specific dates, were solely for the benefit of the parties to such agreement and may be subject to limitations agreed upon by the contracting parties.

 

Pursuant to the Underwriting Agreement, the Company has agreed to pay the Underwriter underwriting commissions and discounts equal to 6.0% of the gross proceeds of the Offering and reimbursement of expenses equal to $125,000.

 

The Securities were offered by the Company pursuant to a registration statement on Form F-3 (File No. 333-287805) originally filed on June 5, 2025, with the SEC under the Securities Act, and declared effective by the SEC on June 13, 2025. The foregoing descriptions of the Underwriting Agreement and Pre-Funded Warrants are not complete and are qualified in their entirety by reference to the full text of the Underwriting Agreement and Pre-Funded Warrant, respectively, copies of which are filed as Exhibit 1.1 and Exhibit 4.1, respectively, to this Current Report on Form 6-K and are incorporated herein by reference.

 

Events

 

On September 25, 2026, the Company issued a press release announcing the Offering. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 6-K and is hereby incorporated by reference herein.

 

1

 

 

INCORPORATION BY REFERENCE

 

This Current Report on Form 6-K, including the exhibits to this Current Report on Form 6-K, is incorporated by reference into and of the Company’s registration statements on Form F-3 or Form S-8 that incorporate by reference material filed by the Company with the SEC. 

 

EXHIBIT INDEX

 

Exhibit
Number
  Description
1.1   Underwriting Agreement, dated September 25, 2026, by and between the Company and Canaccord Genuity LLC
4.1   Form of Pre-Funded Warrant
5.1   Opinion of Erdinast, Ben Nathan, Toledano & Co.
5.2   Opinion of Ellenoff, Grossman & Schole LLP
99.1   Press Release, dated September 25, 2026

 

2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  Arbe Robotics Ltd.
   
Date: September 28, 2026 By:  /s/ Ram Machness
    Name:  Ram Machness
    Title: Chief Executive Officer

 

3

Exhibit 99.1

 

Arbe Robotics Ltd. Announces $15 Million Underwritten Registered Direct Offering

 

TEL AVIV, ISRAEL, Sep. 25, 2026  (GLOBE NEWSWIRE) – Arbe Robotics Ltd. (NASDAQ: ARBE), (TASE: ARBE) (“Arbe” or the “Company”), a global leader in ultra-high-resolution radar solutions, today announced that it has priced an underwritten registered direct offering of 833,334 ordinary shares at a purchase price of $0.60 per share and, in lieu of ordinary shares to certain investors, pre-funded warrants to purchase up to 24,166,666 ordinary shares at a purchase price of $0.5999 per share, which equals the offering price per ordinary share less the $0.0001 exercise price per share of each pre-funded warrant. The pre-funded warrants are immediately exercisable and will not expire until exercised in full. All ordinary shares and pre-funded warrants to be sold in the offering will be offered by the Company.

 

Arbe estimates the gross proceeds from this offering to be approximately $15 million before deducting underwriting discounts and commissions and other offering expenses. The offering is expected to close on or about September 28, 2026, subject to the satisfaction of customary closing conditions. Arbe intends to use the net proceeds from this offering for working capital and general corporate purposes, including, but not limited to, scaling its operations to support growing commercial opportunities, including the recently announced selection of Arbe’s radar technology for an L3 passenger vehicle program of one of the world’s largest automotive groups and its intended expansion into the defense and counter-drone markets, as well as to potentially pursue potential strategic merger and acquisition opportunities.

 

Canaccord Genuity is acting as sole bookrunner for the offering.

 

The securities described above are being offered pursuant to a registration statement on Form F-3 (File No. 333-287805), originally filed on June 5, 2025, with the Securities and Exchange Commission (the “SEC”) and declared effective by the SEC on June 13, 2025. The offering is being made only by means of a prospectus and a prospectus supplement which forms a part of the effective registration statement relating to the offering. A final prospectus supplement and accompanying prospectus relating to the offering will be filed with the SEC. Electronic copies of the final prospectus supplement, when available, may be obtained on the SEC’s website at http://www.sec.gov and may also be obtained, when available, by contacting Canaccord Genuity LLC, Attn: Syndication Department, 1 Post Office Square, 30th Floor, Boston, MA 02109, or by email at prospectus@cgf.com.

 

This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.

 

About Arbe Robotics Ltd.

 

Arbe (NASDAQ: ARBE), a global leader in ultra-high-resolution radar solutions, is redefining radar as a core sensing platform for next-generation mobility and defense. Arbe’s complete radar technology stack, from proprietary chipsets to radar systems and AI algorithms that produce perception-ready data, delivers the detail and real-time processing that demanding sensing applications require. Arbe enables OEMs, Tier-1s, and defense integrators to build more capable perception systems for passenger vehicles, robotaxis, heavy machinery, and counter-drone systems.

 

Headquartered in Tel Aviv, Israel, Arbe also operates offices in the United States, Germany, and China. For more information, visit https://arberobotics.com/ 

 

 

 

Forward-Looking Statements

 

This press release contains “forward-looking statements” within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, both as amended by the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements regarding the expected timing, completion or size of the offering, the expected gross proceeds therefrom, and the intended use of net proceeds therefrom. The words “expect,” “believe,” “estimate,” “intend,” “plan,” “anticipate,” “may,” “should,” “strategy,” “future,” “will,” “project,” “potential” and similar expressions indicate forward-looking statements. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. These risks and uncertainties include the possible delisting of the Company’s ordinary shares from Nasdaq in the event the bid price per share of the Company’s ordinary shares remains below $1.00, the effect on the Israeli economy generally and on the Company’s business resulting from the terrorism and the hostilities in Israel, including the continuing hostilities with Iran, Hezbollah and Hamas and any intensification of hostilities, and the effect of the call-up of a significant portion of its working population, including the Company’s employees, the ability of the Company to develop and market the Alerion radar system and deliver units in a timely and profitable manner, the ability of the Alerion radar system to operate as planned under wartime conditions, and the risks and uncertainties described in “Cautionary Note Regarding Forward-Looking Statements,” “Item 3. Key Information – D. Risk Factors” and “Item 5. Operating and Financial Review and Prospects” and in the Company’s Annual Report on Form 20-F for the year ended December 31, 2025, which was filed with the Securities and Exchange Commission (the “SEC”) on March 27, 2026, as well as other documents filed by the Company with the SEC. Accordingly, you are cautioned not to place undue reliance on these forward-looking statements. Forward-looking statements relate only to the date they were made, and the Company does not undertake any obligation to update forward-looking statements to reflect events or circumstances after the date they were made except as required by law or applicable regulation. Information contained on, or that can be accessed through, the Company’s website or any other website or any social media is expressly not incorporated by reference into and is not a part of this press release.

 

Investor Relations:

 

Ehud Helft & Kenny Green

EK Global Investor Relations

investors@arberobotics.com

+1 212 378 8040

 

 

Filing Exhibits & Attachments

5 documents

Keep reading